2
Views
3
CrossRef citations to date
0
Altmetric
Original Articles

Salvage Chemotherapy in Colorectal Cancer Patients with Good Peformance Status and Young Age after Failure of 5-Fluorouracil/Leucovorin CombinationFootnote

, , &
Pages 46-49 | Published online: 15 Jul 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

J.-F. Seitz, H. Perrier, M. Giovannini, G. Capodano, D. Bernardini & V.-J. Bardou. (1998) 5-Fluorouracil, High-Dose Folinic Acid and Mitomycin C Combination Chemotherapy in Previously Treated Patients with Advanced Colorectal Carcinoma. Journal of Chemotherapy 10:3, pages 258-265.
Read now

Articles from other publishers (2)

E Van Cutsem, D Cunningham, W.W Ten Bokkel Huinink, C.J.A Punt, C.G Alexopoulos, L Dirix, M Symann, G.H Blijham, P Cholet, G Fillet, C Van Groeningen, J.M Vannetzel, F Levi, G Panagos, C Unger, J Wils, C Cote, C Blanc, P Hérait & H Bleiberg. (1999) Clinical activity and benefit of irinotecan (CPT-11) in patients with colorectal cancer truly resistant to 5-fluorouracil (5-FU). European Journal of Cancer 35:1, pages 54-59.
Crossref
John A. Conti, Nancy E. Kemeny, Leonard B. Saltz, A. McKenzie André, Dennis D. Grossano & Joseph R. Bertino. (1995) Continuous infusion fluorouracil/leucovorin and bolus mitomycin-C as a salvage regimen for patients with advanced colorectal cancer. Cancer 75:3, pages 769-774.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.